Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Engineered receptor-biased IL-2-drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy.

Autoimmune and inflammatory diseases arise from a breakdown of immune tolerance driven by hyperactivation of effector lymphocytes and dysfunction of regulatory T (Treg) cells. Interleukin-2 (IL-2) supports both Treg maintenance and effector cell responses, necessitating careful dose optimization for selective immune re...

Jing Li, Shan-Bo Yang, Ye-Shuang Yuan et al. · 0 citations
Review Open access Jul 2026

RNA m6A methylation writers in autoimmune diseases: structure, function, and therapeutic opportunities

This review focuses on the roles and mechanisms of writer‑mediated m6A modification in various immune cells but also summarizes its pharmacological modulators, which represents a key advantage over previous reviews.

Xue-Feng Gao, Gao-Na Shi, Ya-Nan Wang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.